- Home
- SWIN vs LUMO Comparison
SWIN vs LUMO Comparison
Compare SWIN & LUMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- LUMO
- Stock Information
- Founded
- SWIN 2017
- LUMO 2011
- Country
- SWIN Hong Kong
- LUMO United States
- Employees
- SWIN N/A
- LUMO N/A
- Industry
- SWIN
- LUMO Biotechnology: Pharmaceutical Preparations
- Sector
- SWIN
- LUMO Health Care
- Exchange
- SWIN Nasdaq
- LUMO Nasdaq
- Market Cap
- SWIN 41.7M
- LUMO 37.7M
- IPO Year
- SWIN 2023
- LUMO N/A
- Fundamental
- Price
- SWIN $2.50
- LUMO $4.34
- Analyst Decision
- SWIN
- LUMO Buy
- Analyst Count
- SWIN 0
- LUMO 4
- Target Price
- SWIN N/A
- LUMO $9.38
- AVG Volume (30 Days)
- SWIN 105.8K
- LUMO 136.8K
- Earning Date
- SWIN 11-29-2024
- LUMO 11-07-2024
- Dividend Yield
- SWIN N/A
- LUMO N/A
- EPS Growth
- SWIN N/A
- LUMO N/A
- EPS
- SWIN N/A
- LUMO N/A
- Revenue
- SWIN $3,437,000.00
- LUMO $2,205,000.00
- Revenue This Year
- SWIN N/A
- LUMO $184.11
- Revenue Next Year
- SWIN N/A
- LUMO N/A
- P/E Ratio
- SWIN N/A
- LUMO N/A
- Revenue Growth
- SWIN N/A
- LUMO 26.94
- 52 Week Low
- SWIN $2.01
- LUMO $1.37
- 52 Week High
- SWIN $72.55
- LUMO $4.58
- Technical
- Relative Strength Index (RSI)
- SWIN 46.05
- LUMO 55.12
- Support Level
- SWIN $2.15
- LUMO $4.30
- Resistance Level
- SWIN $2.60
- LUMO $4.39
- Average True Range (ATR)
- SWIN 0.23
- LUMO 0.08
- MACD
- SWIN 0.00
- LUMO -0.03
- Stochastic Oscillator
- SWIN 50.72
- LUMO 27.27
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About LUMO Lumos Pharma Inc.
Lumos Pharma Inc is a biopharmaceutical company that develops treatments for cancer and rare diseases. It carries out both clinical-stage and preclinical research on a range of molecules that help the immune system fight off cancer cells. The treatments are available orally and can be used in conjunction with other cancer therapies. The company also researches an Ebola vaccine. Lumos contracts with manufacturing organizations to make their treatments, engages in partnerships with pharmaceutical companies, and operates in the United States.